Trade Tricida, Inc. - TCDA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Trading Conditions
| Spread | 0.0129 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.0308% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.0137% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Key Stats
| Prev. Close* | 0.2183 |
| Open* | 0.2257 |
| 1-Year Change* | -97.03% |
| Day's Range* | 0.2257 - 0.2257 |
| 52 wk Range | 0.2053-13.85 |
| Average Volume (10 days) | 10.8359 |
| Average Volume (3 months) | 163.877 |
| Market Cap | 12.0525 |
| P/E Ratio | N/A |
| Shares Outstanding | 58028300 |
| Revenue | N/A |
| EPS | -2.37405 |
| Dividend (Yield %) | N/A |
| Beta | 0.09335 |
| Next Earnings Date | Mar 27, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 30, 2022 | 0.2183 | -0.0402 | -15.55% | 0.2585 | 0.2606 | 0.2166 |
| Nov 29, 2022 | 0.2651 | -0.0091 | -3.32% | 0.2742 | 0.2791 | 0.2350 |
| Nov 28, 2022 | 0.2606 | 0.0407 | 18.51% | 0.2199 | 0.2875 | 0.2139 |
| Nov 25, 2022 | 0.2002 | 0.0002 | 0.10% | 0.2000 | 0.2383 | 0.1958 |
| Nov 23, 2022 | 0.2003 | -0.0280 | -12.26% | 0.2283 | 0.2596 | 0.2003 |
| Nov 22, 2022 | 0.2023 | -0.0251 | -11.04% | 0.2274 | 0.2310 | 0.2010 |
| Nov 21, 2022 | 0.2181 | -0.0257 | -10.54% | 0.2438 | 0.2447 | 0.2181 |
| Nov 18, 2022 | 0.2475 | -0.0131 | -5.03% | 0.2606 | 0.2645 | 0.2350 |
| Nov 17, 2022 | 0.2577 | 0.0226 | 9.61% | 0.2351 | 0.2660 | 0.2320 |
| Nov 16, 2022 | 0.2355 | 0.0007 | 0.30% | 0.2348 | 0.2510 | 0.2153 |
| Nov 15, 2022 | 0.2351 | -0.0289 | -10.95% | 0.2640 | 0.2740 | 0.2153 |
| Nov 14, 2022 | 0.2597 | 0.0052 | 2.04% | 0.2545 | 0.3165 | 0.2352 |
| Nov 11, 2022 | 0.2547 | 0.0185 | 7.83% | 0.2362 | 0.2832 | 0.2259 |
| Nov 10, 2022 | 0.2246 | -0.0017 | -0.75% | 0.2263 | 0.2473 | 0.2154 |
| Nov 9, 2022 | 0.2131 | -0.0351 | -14.14% | 0.2482 | 0.2548 | 0.2131 |
| Nov 8, 2022 | 0.2548 | -0.0281 | -9.93% | 0.2829 | 0.2830 | 0.2547 |
| Nov 7, 2022 | 0.2777 | 0.0138 | 5.23% | 0.2639 | 0.2900 | 0.2526 |
| Nov 4, 2022 | 0.2772 | 0.0100 | 3.74% | 0.2672 | 0.2971 | 0.2473 |
| Nov 3, 2022 | 0.2686 | -0.0015 | -0.56% | 0.2701 | 0.2755 | 0.2430 |
| Nov 2, 2022 | 0.2721 | -0.0320 | -10.52% | 0.3041 | 0.3074 | 0.2692 |
Tricida, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Operating Expense | 27.183 | 47.122 | 103.595 | 178.824 | 251.4 | 159.078 |
| Selling/General/Admin. Expenses, Total | 5.363 | 11.216 | 18.001 | 45.796 | 102.983 | 37.59 |
| Research & Development | 21.82 | 35.906 | 85.594 | 133.028 | 148.417 | 115.364 |
| Operating Income | -27.183 | -47.122 | -103.595 | -178.824 | -251.4 | -159.078 |
| Interest Income (Expense), Net Non-Operating | -1.468 | 5.832 | -3.137 | -5.744 | -18.407 | -17.102 |
| Net Income Before Taxes | -28.651 | -41.29 | -102.808 | -176.905 | -264.791 | -176.566 |
| Net Income After Taxes | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Net Income Before Extra. Items | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Net Income | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Income Available to Common Excl. Extra. Items | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Income Available to Common Incl. Extra. Items | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Diluted Net Income | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Diluted Weighted Average Shares | 40.1894 | 40.1894 | 42.3862 | 47.5212 | 50.0277 | 51.2807 |
| Diluted EPS Excluding Extraordinary Items | -0.7129 | -1.02738 | -2.42551 | -3.72072 | -5.29288 | -3.44313 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||||
| Diluted Normalized EPS | -0.7129 | -1.02738 | -2.42551 | -3.72072 | -5.29164 | -3.32371 |
| Other, Net | 3.924 | 7.663 | 5.016 | -0.386 | ||
| Unusual Expense (Income) | 6.124 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Total Operating Expense | 48.194 | 29.331 | 35.687 | 45.866 | 27.674 |
| Selling/General/Admin. Expenses, Total | 9.895 | 9.55 | 9.052 | 9.093 | 9.17 |
| Research & Development | 32.175 | 19.781 | 26.635 | 36.773 | 18.504 |
| Unusual Expense (Income) | 6.124 | 0 | 0 | 0 | 0 |
| Operating Income | -48.194 | -29.331 | -35.687 | -45.866 | -27.674 |
| Interest Income (Expense), Net Non-Operating | -5.613 | -3.926 | -3.994 | -4.069 | -1.973 |
| Other, Net | 0.445 | -0.296 | 0.006 | -0.041 | 0.008 |
| Net Income Before Taxes | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Net Income After Taxes | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Net Income Before Extra. Items | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Net Income | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Income Available to Common Excl. Extra. Items | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Income Available to Common Incl. Extra. Items | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Diluted Net Income | -53.362 | -33.553 | -39.675 | -49.976 | -29.639 |
| Diluted Weighted Average Shares | 50.2477 | 50.2948 | 50.4349 | 54.1434 | 57.719 |
| Diluted EPS Excluding Extraordinary Items | -1.06198 | -0.66713 | -0.78666 | -0.92303 | -0.51351 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.9401 | -0.66912 | -0.78666 | -0.92303 | -0.51351 |
- Annual
- Quarterly
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 27.203 | 69.424 | 244.347 | 312.742 | 314.015 | 145.536 |
| Cash and Short Term Investments | 26.45 | 67.514 | 241.078 | 307.998 | 309.527 | 140.532 |
| Cash & Equivalents | 5.682 | 9.774 | 37.172 | 18.574 | 137.857 | 21.113 |
| Short Term Investments | 20.768 | 57.74 | 203.906 | 289.424 | 171.67 | 119.419 |
| Prepaid Expenses | 0.753 | 1.91 | 3.269 | 4.744 | 4.488 | 5.004 |
| Total Assets | 27.684 | 70.574 | 247.849 | 371.826 | 351.685 | 168.506 |
| Property/Plant/Equipment, Total - Net | 0.481 | 1.15 | 1.215 | 12.104 | 14.913 | 12.927 |
| Property/Plant/Equipment, Total - Gross | 1.449 | 2.453 | 3.136 | 14.752 | 19.138 | 17.448 |
| Accumulated Depreciation, Total | -0.968 | -1.303 | -1.921 | -2.648 | -4.225 | -4.521 |
| Total Current Liabilities | 8.24 | 11.222 | 14.804 | 39.763 | 34.258 | 29.48 |
| Accounts Payable | 2.104 | 3.861 | 8.46 | 5.911 | 3.508 | 10.023 |
| Accrued Expenses | 2.765 | 7.361 | 6.344 | 33.852 | 30.75 | 19.457 |
| Notes Payable/Short Term Debt | 3.371 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 8.429 | 11.545 | 53.324 | 107.943 | 242.814 | 168.288 |
| Total Long Term Debt | 0 | 0 | 38.071 | 58.374 | 195.308 | 127.512 |
| Other Liabilities, Total | 0.189 | 0.323 | 0.449 | 9.806 | 13.248 | 11.296 |
| Total Equity | 19.255 | 59.029 | 194.525 | 263.883 | 108.871 | 0.218 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 | |
| Preferred Stock - Non Redeemable, Net | 66.883 | 147.07 | ||||
| Common Stock | 0.002 | 0.002 | 0.042 | 0.05 | 0.05 | 0.055 |
| Additional Paid-In Capital | 0.466 | 1.356 | 386.83 | 632.647 | 742.555 | 810.618 |
| Retained Earnings (Accumulated Deficit) | -48.096 | -89.386 | -192.194 | -369.007 | -633.798 | -810.364 |
| Unrealized Gain (Loss) | 0 | -0.013 | -0.153 | 0.193 | 0.064 | -0.091 |
| Total Liabilities & Shareholders’ Equity | 27.684 | 70.574 | 247.849 | 371.826 | 351.685 | 168.506 |
| Total Common Shares Outstanding | 40.1894 | 40.1894 | 42.1483 | 49.7632 | 50.2108 | 55.3635 |
| Long Term Investments | 2.287 | 46.98 | 22.757 | 10.043 | ||
| Long Term Debt | 38.071 | 58.374 | 195.308 | 127.512 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 220.72 | 181.027 | 151.174 | 145.536 | 127.995 |
| Cash and Short Term Investments | 217.731 | 175.766 | 146.77 | 140.532 | 123.726 |
| Cash & Equivalents | 40.51 | 22.865 | 16.988 | 21.113 | 17.712 |
| Short Term Investments | 177.221 | 152.901 | 129.782 | 119.419 | 106.014 |
| Prepaid Expenses | 2.989 | 5.261 | 4.404 | 5.004 | 4.269 |
| Total Assets | 235.168 | 194.948 | 164.586 | 168.506 | 140.414 |
| Property/Plant/Equipment, Total - Net | 14.448 | 13.921 | 13.412 | 12.927 | 12.419 |
| Long Term Investments | 0 | 0 | 0 | 10.043 | 0 |
| Total Current Liabilities | 40.205 | 24.868 | 25.731 | 29.48 | 24.994 |
| Accounts Payable | 5.321 | 2.738 | 3.261 | 10.023 | 5.535 |
| Accrued Expenses | 34.884 | 22.13 | 22.47 | 19.457 | 19.459 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 173.607 | 160.019 | 162.684 | 168.288 | 230.714 |
| Total Long Term Debt | 120.775 | 122.951 | 125.194 | 127.512 | 194.894 |
| Long Term Debt | 120.775 | 122.951 | 125.194 | 127.512 | 194.894 |
| Other Liabilities, Total | 12.627 | 12.2 | 11.759 | 11.296 | 10.826 |
| Total Equity | 61.561 | 34.929 | 1.902 | 0.218 | -90.3 |
| Common Stock | 0.05 | 0.05 | 0.05 | 0.055 | 0.055 |
| Additional Paid-In Capital | 748.712 | 755.654 | 762.317 | 810.618 | 737.685 |
| Retained Earnings (Accumulated Deficit) | -687.16 | -720.713 | -760.388 | -810.364 | -827.663 |
| Unrealized Gain (Loss) | -0.041 | -0.062 | -0.077 | -0.091 | -0.377 |
| Total Liabilities & Shareholders’ Equity | 235.168 | 194.948 | 164.586 | 168.506 | 140.414 |
| Total Common Shares Outstanding | 50.2727 | 50.4287 | 50.4476 | 55.3635 | 55.3972 |
| Redeemable Preferred Stock | 0 | 0 |
- Annual
- Quarterly
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Net income/Starting Line | -28.651 | -41.29 | -102.808 | -176.813 | -264.791 | -176.566 |
| Cash From Operating Activities | -23.115 | -40.401 | -94.856 | -129.59 | -231.187 | -140.056 |
| Cash From Operating Activities | 0.424 | 0.335 | 0.618 | 0.757 | 0.897 | 0.442 |
| Non-Cash Items | 1.857 | -4.815 | 5.186 | 25.331 | 37.272 | 42.183 |
| Changes in Working Capital | 3.255 | 5.369 | 2.148 | 21.135 | -4.565 | -6.115 |
| Cash From Investing Activities | -20.281 | -37.947 | -148.354 | -127.498 | 140.277 | 64.218 |
| Capital Expenditures | -0.249 | -1.004 | -0.855 | -1.423 | -1.605 | -0.099 |
| Other Investing Cash Flow Items, Total | -20.032 | -36.943 | -147.499 | -126.075 | 141.882 | 64.317 |
| Cash From Financing Activities | 42.973 | 82.44 | 270.608 | 238.49 | 210.193 | -40.906 |
| Issuance (Retirement) of Stock, Net | 43.015 | 82.479 | 238.467 | 220.966 | 2.017 | 42.417 |
| Issuance (Retirement) of Debt, Net | -0.042 | -0.039 | 38.705 | 18.445 | 208.176 | -83.323 |
| Net Change in Cash | -0.423 | 4.092 | 27.398 | -18.598 | 119.283 | -116.744 |
| Cash Interest Paid | 1.612 | 3.348 | 9.084 | 8.774 | ||
| Financing Cash Flow Items | -6.564 | -0.921 | 0 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -53.362 | -86.915 | -126.59 | -176.566 | -29.639 |
| Cash From Operating Activities | -30.978 | -73.107 | -101.996 | -140.056 | -26.402 |
| Cash From Operating Activities | 0.134 | 0.253 | 0.351 | 0.442 | 0.081 |
| Non-Cash Items | 15.02 | 24.179 | 33.254 | 42.183 | 6.694 |
| Cash Interest Paid | 1.774 | 5.274 | 5.274 | 8.774 | 0 |
| Changes in Working Capital | 7.23 | -10.624 | -9.011 | -6.115 | -3.538 |
| Cash From Investing Activities | 16.816 | 40.99 | 63.988 | 64.218 | 23.191 |
| Capital Expenditures | -0.076 | -0.076 | -0.076 | -0.099 | 0 |
| Other Investing Cash Flow Items, Total | 16.892 | 41.066 | 64.064 | 64.317 | 23.191 |
| Cash From Financing Activities | -83.185 | -82.875 | -82.861 | -40.906 | -0.19 |
| Issuance (Retirement) of Stock, Net | 0.115 | 0.448 | 0.462 | 42.417 | 0.008 |
| Issuance (Retirement) of Debt, Net | -83.3 | -83.323 | -83.323 | -83.323 | 0 |
| Net Change in Cash | -97.347 | -114.992 | -120.869 | -116.744 | -3.401 |
| Financing Cash Flow Items | -0.198 |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group 475000+
Traders
71000+
Active clients monthly
$51000000+
Monthly investing volume
$30000000+
Try now Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Tricida Company profile
About Tricida Inc
Tricida, Inc. is a pharmaceutical company, which is focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101). TRC101, is a non-absorbed, orally administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Its Veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. It is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. Its VALOR-CKD trial is a randomized, double-blind, placebo-controlled, time-to-event trial.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Tricida Inc revenues was not reported. Net loss decreased 40% to $126.6M. Lower net loss reflects General and administrative - Balancing decrease of 81% to $12.6M (expense), Research and development - Balancing val decrease of 42% to $64.7M (expense), Stock-Based Compensation decrease of 28% to $11.4M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$4.20 to -$2.52.
| Industry: | Biotechnology & Medical Research (NEC) |
7000 Shoreline Court, Suite 201
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
Income Statement
News
UK crypto: ‘Tension exists between parliament and regulation’, says SNP’s Dr Lisa Cameron
The MP also wants to bring crypto education into schools and universities across the UK
15:19, 1 December 2022
Twitter vs Apple: Musk tries to mend relations with AAPL, as regulators come after Twitter
Musk is under pressure from EU and US regulators while he calms down the dispute with Apple, paying a visit to Tim Cook himself.
14:47, 1 December 2022
S&P 500 rallies as Powell confirms 50bps hike ahead of highly awaited NFP data
Equities take another step higher as dovish expectations start to set in
14:12, 1 December 2022
USD/JPY correction: Yen rally continues on talk of stimulus withdrawal
How solid is further upside for the yen? The data is mixed but increasingly fast-paced
13:22, 1 December 2022
Fed, the dollar and the stock market: Beware of FOMO – 5 charts to watch
The bear-market rally is flooded with euphoria, driving the dollar to decline and equities to gain as investors wager on Fed rate cuts next year.
13:15, 1 December 2022People also watch
Still looking for a broker you can trust?
Join the 475.000+ traders worldwide that chose to trade with Capital.com